首页 › 卵巢癌 › 马萨诸塞州 › Springfield
Springfield MA 卵巢癌临床试验
5项针对 卵巢癌的研究正在 Springfield及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- Baystate Medical Center, Springfield
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
招募中2 期
- Site 0263 - Baystate Medical Center, Springfield
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
招募中
- Baystate Medical Center, Springfield
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Baystate Medical Center, Springfield
Integrated Cancer Repository for Cancer Research
招募中观察性研究欢迎健康志愿者
- Holyoke Medical Center, Holyoke · 距离 7 英里
其他城市的 卵巢癌试验
- Houston, TX89 项研究
- New York City, NY69 项研究
- Boston, MA61 项研究
- Los Angeles, CA50 项研究
- Nashville, TN49 项研究
- Arlington, VA46 项研究
- Philadelphia, PA44 项研究
- Columbus, OH39 项研究
- St. Louis, MO38 项研究
- Chicago, IL36 项研究
- San Antonio, TX31 项研究
- Cleveland, OH30 项研究
Springfield的其他研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月5日。每项研究自行设定入选标准,由研究团队决定谁能参与。